↓ Skip to main content

mTOR

Overview of attention for book
Cover of 'mTOR'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life.
  3. Altmetric Badge
    Chapter 2 Biochemical and Pharmacological Inhibition of mTOR by Rapamycin and an ATP-Competitive mTOR Inhibitor.
  4. Altmetric Badge
    Chapter 3 Evaluation of the Nutrient-Sensing mTOR Pathway.
  5. Altmetric Badge
    Chapter 4 mTOR Activity Under Hypoxia.
  6. Altmetric Badge
    Chapter 5 Isolation of the mTOR Complexes by Affinity Purification.
  7. Altmetric Badge
    Chapter 6 An In Vitro Assay for the Kinase Activity of mTOR Complex 2
  8. Altmetric Badge
    Chapter 7 Overexpression or Downregulation of mTOR in Mammalian Cells.
  9. Altmetric Badge
    Chapter 8 Detection of Cytoplasmic and Nuclear Functions of mTOR by Fractionation.
  10. Altmetric Badge
    Chapter 9 Evaluation of rapamycin-induced cell death.
  11. Altmetric Badge
    Chapter 10 Evaluation of mTOR-Regulated mRNA Translation
  12. Altmetric Badge
    Chapter 11 A Genome-wide RNAi Screen for Polypeptides that Alter rpS6 Phosphorylation.
  13. Altmetric Badge
    Chapter 12 Immunohistochemical Analysis of mTOR Activity in Tissues.
  14. Altmetric Badge
    Chapter 13 Assessing Cell Size and Cell Cycle Regulation in Cells with Altered TOR Activity.
  15. Altmetric Badge
    Chapter 14 Quantitative Visualization of Autophagy Induction by mTOR Inhibitors.
  16. Altmetric Badge
    Chapter 15 The In Vivo Evaluation of Active-Site TOR Inhibitors in Models of BCR-ABL+ Leukemia.
  17. Altmetric Badge
    Chapter 16 Inducible raptor and rictor Knockout Mouse Embryonic Fibroblasts.
  18. Altmetric Badge
    Chapter 17 Expanding Human T Regulatory Cells with the mTOR-Inhibitor Rapamycin.
  19. Altmetric Badge
    Chapter 18 Rapamycin-induced enhancement of vaccine efficacy in mice.
  20. Altmetric Badge
    Chapter 19 Utilizing a Retroviral RNAi System to Investigate In Vivo mTOR Functions in T Cells.
  21. Altmetric Badge
    Chapter 20 Exploring Functional In Vivo Consequences of the Selective Genetic Ablation of mTOR Signaling in T Helper Lymphocytes.
  22. Altmetric Badge
    Chapter 21 Evaluating the Therapeutic Potential of mTOR Inhibitors Using Mouse Genetics.
  23. Altmetric Badge
    Chapter 22 Inhibition of PI3K-Akt-mTOR Signaling in Glioblastoma by mTORC1/2 Inhibitors.
  24. Altmetric Badge
    Chapter 23 Assessing the Function of mTOR in Human Embryonic Stem Cells.
  25. Altmetric Badge
    Chapter 24 Video-EEG Monitoring Methods for Characterizing Rodent Models of Tuberous Sclerosis and Epilepsy.
  26. Altmetric Badge
    Chapter 25 A Genetic Model to Dissect the Role of Tsc-mTORC1 in Neuronal Cultures.
  27. Altmetric Badge
    Chapter 26 Tissue-specific ablation of tsc1 in pancreatic Beta-cells.
  28. Altmetric Badge
    Chapter 27 A Mouse Model of Diet-Induced Obesity and Insulin Resistance
  29. Altmetric Badge
    Chapter 28 Rapamycin as immunosuppressant in murine transplantation model.
  30. Altmetric Badge
    Chapter 29 Development of ATP-Competitive mTOR Inhibitors.
Attention for Chapter 11: A Genome-wide RNAi Screen for Polypeptides that Alter rpS6 Phosphorylation.
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
A Genome-wide RNAi Screen for Polypeptides that Alter rpS6 Phosphorylation.
Chapter number 11
Book title
mTOR
Published in
Methods in molecular biology, September 2011
DOI 10.1007/978-1-61779-430-8_11
Pubmed ID
Book ISBNs
978-1-61779-429-2, 978-1-61779-430-8
Authors

Papageorgiou A, Avruch J, Angela Papageorgiou, Joseph Avruch

Editors

Thomas Weichhart

Abstract

Mammalian target of rapamycin (mTOR) is a giant protein kinase that controls cell proliferation, growth, and metabolism. mTOR is regulated by nutrient availability, by mitogens, and by stress, and operates through two independently regulated hetero-oligomeric complexes. We have attempted to identify the cellular components necessary to maintain the activity of mTOR complex 1 (mTORC1), the amino acid-dependent, rapamycin-inhibitable complex, using a whole genome approach involving RNAi-induced depletion of cellular polypeptides. We have used a pancreatic ductal adenocarcinoma (PDAC) cell line, Mia-PaCa for this screen; as with many pancreatic cancers, these cells exhibit constitutive activation of mTORC1. PDAC is the most common form of pancreatic cancer and the 5-year survival rate remains 3-5% despite current nonspecific and targeted therapies. Although rapamycin-related mTOR inhibitors have yet to demonstrate encouraging clinical responses, it is now evident that this class of compounds is capable of only partial mTORC1 inhibition. Identifying previously unappreciated proteins needed for maintenance of mTORC1 activity may provide new targets and lead to the development of beneficial therapies for pancreatic cancer.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 25%
Researcher 3 25%
Student > Doctoral Student 1 8%
Other 1 8%
Professor > Associate Professor 1 8%
Other 0 0%
Unknown 3 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 25%
Biochemistry, Genetics and Molecular Biology 2 17%
Engineering 2 17%
Medicine and Dentistry 1 8%
Computer Science 1 8%
Other 0 0%
Unknown 3 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2012.
All research outputs
#18,305,470
of 22,663,969 outputs
Outputs from Methods in molecular biology
#7,813
of 13,024 outputs
Outputs of similar age
#109,606
of 131,785 outputs
Outputs of similar age from Methods in molecular biology
#25
of 49 outputs
Altmetric has tracked 22,663,969 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,024 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,785 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.